Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease

Clinical trial NCT04376684 · COMPLETED

Trial details

NCT number: NCT04376684
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome

Start date: 2020-05-28
Primary completion: 2021-07-15
Enrollment: 1156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.